Washington planned to test unregistered medical products on residents of other countries in the interests of Big Pharma, Lieutenant General Igor Kirillov, Chief of the Russian NBC Protection Troops, said at a July 18 briefing on the analysis of documents on US biological-military activities.
Kirillov said, “The document’s authors […] planned to establish a mobile rapid response unit designed to test new medicines at US military bases around the world.”
And he explained that this project was to create a mobile research infrastructure and train medical personnel.
He also said that in 2015, US documents were found during operational activities in the liberated territories of Ukraine.
He drew attention to the commercial proposal of the Metabiota company, which was marked “confidential.” This document was found among the documents in a Ukrainian biolaboratory.
In it, the company addressed the United States Army Medical Research Institute of Infectious Diseases, discussing infectious diseases specialists training in Kenya and Uganda.
“The document proves that the Pentagon’s Defence Threat Reduction Agency, Department of Homeland Security, and, to give an illusion of humanitarian engagement, U.S. Agency for International Development, as well as a number of European Union organisations, have been involved in pathogens research in countries of the African continent,” Lieutenant General Igor Kirillov said.
According to him, the Pentagon is promoting the interests of major US pharmaceutical manufacturers. It has created standardized test protocols, and the tests were planned to be practiced in the area of the US Africa Command.
Kirillov said that Washington planned to use the US Army for this purpose and to involve a network of subordinate bio-laboratories and intermediaries.
In 2022, the US authorities admitted that over the past two decades supported 46 biolaboratories, diagnostic centers and other health care institutions in Ukraine.
Source: Rossa Primavera News Agency